Brucellosis: An Overview

Emerging Infectious Diseases

Volumn 3, Issue 2, 1997, Pages 213-221

  Corbel, Michael J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN;

ANIMAL; BRUCELLA; BRUCELLOSIS; CATTLE; GENETICS; HUMAN; IMMUNOLOGY; PATHOGENICITY; REVIEW;

ANIMALS; ANTIGENS, BACTERIAL; BRUCELLA; BRUCELLOSIS; CATTLE; HUMANS;

EID: 0031111368     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0302.970219     Document Type: Article

References (68)

1. Amato Gauci AJ. The return of brucellosis. Maltese Medical Journal 1995;7:7-8.
2. Garcia Carrillo C. Animal and human brucellosis in the Americas. Paris: OIE, 1990: 287.
3. Lopez Merino A. Brucellosis in Latin America. Young EJ, Corbel MH, editors. Brucellosis; clinical and laboratory aspects. Boca Raton: CRC Press Inc., 1989:151-61.
4. Mantur BG, Mangalgi SS, Mulimani B. Brucella melitensis-a sexually transmissible agent. Lancet 1996;347:1763.
5. Tessaro SV, Forbes LB. Brucella suis biotype 4; a case of granulomatous nephritis in a barren ground caribou (Rangifer tarandus groenlandicus L) with a review of the distribution of rangiferine brucellosis in Canada. J Wildlife Dis 1986;22:479-88.
6. Carmichael LE. Brucella canis. In: Nielsen K, Duncan JR, editors. Animal brucellosis. Boca Raton: CRC Press Inc.: 1990,335-50.
7. Ross HM, Foster G, Reid RJ, Jabans KL, MacMillan AP. Brucella infection in sea mammals. Vet Rec 1994;132:359.
8. Ewalt DR, Payeur JB, Martin BM, Cummins DR, Miller WG. Characteristics of a Brucella species from a bottlenose dolphin (Tursiops truncatus). J Vet Diagn Invest 1994;6:448-52.
9. De Ley J, Mannheim W, Segers P, Lievens A. Ribosomal ribonucleic acid cistron similarities and taxonomic neighbourhood of Brucella and CDC Group Vd. Int J Syst Bacteriol 1987;37:35-42.
10. Verger JM, Grimont F, Grimont PAD, Grayon M. Brucella A monospecific genus as shown by deoxyribonucleic acid hybridization. Int J Syst Bacteriol 1985;35:292-5.
11. Alton GG, Jones LM, Pietz DE. Laboratory techniques in brucellosis. Geneva: World Health Organization 1975.
12. Corbel MJ, Morgan WJB. Genus Brucella Meyer and Shaw 1920, 173 AL. In: Holt JG, editor. Bergey's manual of systematic bacteriology vol. 1. Baltimore (MD): Williams and Wilkins, 1984:377-88.
13. Corbel MJ. Identification of dye-sensitive strains of Brucella melitensis. J Clin Microbiol 1991;29:1066-8.
14. Corbel MJ, Thomas EL. Use of phage for the identification of Brucella canis and Brucella ovis cultures. Res Vet Sci 1985;35:35-40.
15. Banai M, Mayer I, Cohen A. Isolation, identification and characterization in Israel of Brucella melitensis biovar 1 atypical strains susceptible to dyes and penicillin, indication of the evolution of a new variant. J Clin Microbiol 1990;28:1057-9.
16. Allardet-Servent A, Bourg G, Ramuz M, Bellis M, Roizes G. DNA polymorphism in strains of the genus Brucella. J Bacteriol 1988;170:4603-7.
17. O'Hara MJ, Collins DM, Lisle GW. Restriction endonuclease analysis of Brucella ovis and other Brucella species. Vet Microbiol 1985;10:425-9.
18. Ficht TA, Bearden SW, Sowa BA, Adams LG. DNA sequence and expression of the 36-kilodalton outer membrane protein gene of Brucella abortus. Infect Immun 1989;57:3281-91.
19. Cellier MFM, Teyssier J, Nicolas M., Liautard JB, Marti J, SriWidada J. Cloning and characterization of the Brucella ovis heat shock protein DnaK functionally expressed in Escherichia coli. J Bacteriol 1992;174:8036-42.
20. Sangari FJ, García-Lobo JM, Aguero J. The Brucella abortus vaccine strain B19 carries a deletion in the erythritol catabolic genes. FEMS Microbiol Lett 1994;121:337-42.
21. Douglas JT, Rosenberg EY, Nikaido H, Verstreate DR, Winter AJ. Porins of Brucella species. Infect Immun 1984;44:16-21.
22. Ficht TA, Husseinen HS, Derr J, Bearden SW. Species-specific sequences at the omp2 locus of Brucella type strains. Int J Syst. Bacteriol 1996;46:329-31.
23. Cloeckaert A, Verger J-M, Grayon M, Grepinet O. Restriction site polymorphism of the genes encoding the major 25kDa and 36kDa outer membrane proteins of Brucella. Microbiology 1995;141:2111-21.
24. Cloeckaert A, Salih-Alj Debarrh H, Zygmunt MS, Dubray G. Polymorphism at the dnak locus of Brucella species and identification of a Brucella melitensis species-specific marker. J Med Microbiol 1996;45:200-13.
25. Michaux S, Paillisson J, Carles-Nurit MJ, Bourg G, Allardet Servent A, Ramuz M. Presence of two independent chromosomes in the Brucella melitensis 16M genome. J Bacteriol 1993;175:701-5.
26. Jumas-Bitlak E, Maugard C, Michaux-Charachon S, Allardet-Servent A, Perrin A, O'Callaghan D. Study of the organization of the genomes of Escherichia coli, Brucella melitensis and Agrobacterium tumefaciens by insertion of a unique restriction site. Microbiology 1995;141:2425-32.
27. Rigby CE, Fraser ADE. Plasmid transfer and plasmid-mediated genetic exchange in Brucella abortus. Can J Vet Res 1989;53:326-30.
28. Cieslak TJ, Robb ML, Drabick CJ, Fisher GW. Catheter-associated sepsis caused by Ochrobactrum anthropi: report of a case and review of related non-fermentative bacteria. Clin Infect Dis 1992;14:902-7.
29. Da Costa M, Guillou J-P, Garin-Bastuji B, TbiJbaud M, Dubray G. Specificity of six gene sequences for the detection of the genus Brucella by DNA amplification. J Appl Bacteriol 1996;81:267-75.
30. Minnick M F, Stiegler G L. Nucleotide sequence and comparison of the 5S ribosomal genes of Rochalimaea henselae, R. quintana and Brucella abortus. Nucleic Acids Res 1993;21:2518.
31. Relman DA, Lepp PW, Sadler KN, Schmidt TM. Phylogenetic relationships among the agent of bacillary angiomatosis, Bartonella bacilliformis, and other alpha-proteobacteria. Mol. Microbiol 1992;6:1801-7.
32. Perry MB, Bundle DR. Lipopolysaccharide antigens and carbohydrates of Brucella. In: Adams LG, editor. Advances in Brucellosis Research Austin (TX): Texas A & M University, 1990;76-88.
33. Bundle DR, Cherwonogrodzky JW, Gidney MAJ, Meikle PJ, Perry MB, Peters T. Definition of Brucella A and M epitopes by monoclonal typing reagents and synthetic oligosaccharides. Infect Immun 1989;57:2829-36.
34. Wilson GS, Miles AA. The serological differentiation of smooth strains of the Brucella group. British Journal of Experimental Pathology 1932;13:1-13.
35. Goldbaum FA, Leoni J, Walach JC, Fossati CA. Characterisation of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis. J Clin Microbiol 1993;31:2141-5.
36. Goldbaum FA, Morelli L, Wallach J, Rubbi CP, Fossati CA. Human brucellosis: immunoblotting analysis of three Brucella abortus antigenic fractions allows the detection of components of diagnostic importance. Medicina 1991;51:227-32.
37. Corbel MJ. The immunogenic activity of ribosomal fractions derived from Brucella abortus. Journal of Hygiene, Cambridge 1976;76:65-74.
38. Bachrach G, Banai M, Bardenstein S, Hoida G, Genizi A, Bercovier H. Brucella ribosomal protein L7 / L12 is a major component in the antigenicity of Brucellin INRA for delayed hypersensitivity in Brucella-sensitized guinea- pigs. Infect Immun 1994;62:5361-6.
39. Oliveira S, Splitter GA. Immunization of mice with recombinant L7 / L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 1996;14:959-62.
40. Zhan Y, Cheers C. Differential activation of Brucella-reactive CD4+ cells by Brucella infection or immunization with antigenic extracts. Infect Immun 1995;63:969-95.
41. Caron E, Peyrard T, Kohler S, Cabane S, Liautard J-P, Dornand J. Live Brucella spp. fail to induce tumour necrosis factor alpha excretion upon infection of U937-derived phagocytes. Infect Immun 1994;62:5267-74.
42. Dubray G. Protective antigens in brucellosis. Annales de l'Institut Pasteur, Microbiologie 1987;138:84-7.
43. Canning PC, Roth JA, Deyoe BL. Release of 5′-guanosine monophosphate and adenine by Brucella abortus and the intracellular survival of the bacteria. J Infect Dis 1986; 154:464-70.
44. Bricker BJ, Tabatabai LB, Judge BA, Deyoe BL, Mayfield JE. Cloning, expression and occurrence of the Brucella Cu-Zn dismutase. Infect Immun 1990;58:2933-9.
45. Lin J, Ficht TA. Protein synthesis in Brucella abortus induced during macrophage infection. Infect Immun 1995;63:1409-14.
46. Tatum FM, Cheville NF, Morfitt D. Cloning, characterisation and construction of htr A and htr A - like mutants of Brucella abortus and their survival in BALB/C mice. Microb Pathog 1994;17:23-36.
47. Tatum FM, Morfitt DC, Halling SM. Construction of a Brucella abortus Rec A mutant and its survival in mice. Microb Pathog 1993;14:177-85.
48. Santini C, Baiocchi P, Berardelli A, Venditti M, Serra P. A case of brain abscess due to Brucella melitensis. Clin Infect Dis 1994;19:977-8.
49. Potasman I, Even L, Banai M, Cohen E, Angel D, Jaffe M. Brucellosis: an unusual diagnosis for a seronegative patient with abscesses, osteomyelitis and ulcerative colitis. Rev Clin Dis 1991;13:1039-42.
50. Shakir RA, Al-Din ASN, Araj GF, Lulu AR, Mousa AR, Saadah MA. Clinical diagnosis of neurobrucellosis. A report on 19 cases. Brain 1987;110:213-23.
51. Young EJ. An overview of human brucellosis. Clin Infect Dis 1995;21:283-90.
52. Madkour MM. Brucellosis. Butterworths, London 1989.
53. Kolman S, Maayan MC, Gotesman G, Roszenstain LA, Wolach B, Lang R. Comparison of the Bactec and lysis concentration method for the recovery of Brucella species from clinical specimens. Eur J Clin Microbiol Infect Dis 1991;10:647-8.
54. Solomon HM, Jackson D. Rapid diagnosis of Brucella melitensis in blood; some operational characteristics of the BACT/ALERT. J Clin Microbiol 1992;28:2139-41.
55. Luzzi GA, Brindle R, Socket PN, Solera J, Klenerman P, Warrell DA. Brucellosis: imported and laboratory-acquired cases, and an overview of treatment trials. Trans Roy Soc Trop Med Hyg 1993;87:138-41.
56. Matar FM, Khreissir IA, Abdonoor AM. Rapid laboratory confirmation of human brucellosis by PCR analysis of a target sequence on the 31-kilodalton Brucella antigen DNA. J Clin Microbiol 1996;34:477-8.
57. Araj GF, Lulu AR, Mustafa MY, Khateeb MI. Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. Journal of Hygiene, Cambridge 1986;97:457-69.
58. Ariza J, Pellicer T, Pallarés R, Foz A, Gudiol F. Specific antibody profile in human brucellosis. Clin Infect Dis 1992;14:131-40.
59. Joint FAO / WHO Expert Committee on Brucellosis. Sixth Report. World Health Organ Tech Rep Ser No. 740. Geneva: World Health Organization, 1986.
60. Ariza J, Gudiol F, Pallarés R, Rufi G, Fernàndez-Viladrich P. Comparative trial of rifampicin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agents Chemother 1985;28:548-51.
61. Akova M, Uzun O, Akalin HE, Hayran M, Unal S, Gur D. Quinolones in the treatment of human brucellosis; comparative trial of ofloxacin-rifampin versus doxycyclinerifampin. J Antimicrob Chemother 1993;37:1831-4.
62. Shakir RA. Neurobrucellosis. Postgrad Med J 1986;62:1077-9.
63. Khuri-Bulos NA, Daoud AH, Azab SM. Treatment of childhood brucellosis: results of a prospective trail on 113 childred. Ped Infect Dis 1993;12:377-81.
64. Corbel MJ. Vaccines against bacterial zoonoses. J Med Microbiol 1997;46:267-9.
65. Crawford RM, Van De Verg L, Yuan L, Hadfield TL, Warren RL, Drazek ES, et al. Deletion of purE attenuates Brucella melitensis infection in mice. Infect Immun 1996;64:2188-92.
66. Xie X. Orally administered brucellosis vaccine Brucella suis strain 2 vaccine. Vaccine 1986;4:212-6.
67. Mustafa AA, Abusowa M. Field-oriented trial of the Chinese Brucella suis strain 2 vaccine in sheep and goats in Libya. Annales de Recherche Veterinaire 1993;24:422-9.
68. Schurig GG, Roop RM, Bagchi T, Boyle S, Buhrman D, Sriranganathan N. Biological properties of RB51. A stable strain of Brucella abortus. Vet Microbiol 1991;28:171-88.